Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies (2016)
Attributed to:
Medical Technologies Innovation and Knowledge Centre Phase 2 Regenerative Devices
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kew384
PubMed Identifier: 27940584
Publication URI: http://europepmc.org/abstract/MED/27940584
Type: Journal Article/Review
Parent Publication: Rheumatology
ISSN: 1462-0324